P
Peter G. Colman
Researcher at Royal Melbourne Hospital
Publications - 254
Citations - 15334
Peter G. Colman is an academic researcher from Royal Melbourne Hospital. The author has contributed to research in topics: Diabetes mellitus & Type 1 diabetes. The author has an hindex of 58, co-authored 231 publications receiving 14183 citations. Previous affiliations of Peter G. Colman include Harvard University & Joslin Diabetes Center.
Papers
More filters
Journal ArticleDOI
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
Anthony C Keech,R. J. Simes,Philip J. Barter,James D. Best,Russell S. Scott,Marja-Riitta Taskinen,Peta M. Forder,Avinesh Pillai,Tamara M. Davis,Paul Glasziou,Paul L. Drury,Y A Kesäniemi,David R. Sullivan,D Hunt,Peter G. Colman,Michael C d'Emden,Malcolm J. Whiting,Christian Ehnholm,Markku Laakso +18 more
TL;DR: Fenofibrate did not significantly reduce the risk of the primary outcome of coronary events, but it did reduce total cardiovascular events, mainly due to fewer non-fatal myocardial infarctions and revascularisations.
Journal ArticleDOI
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
Anthony C Keech,Anthony C Keech,Paul Mitchell,Paula Summanen,Justin O'Day,Tme Davis,Moffitt,M.-R. Taskinen,R. J. Simes,R. J. Simes,Dana Tse,Elizabeth A. Williamson,A Merrifield,Leila Laatikainen,Michael C d'Emden,D C Crimet,Rachel O'Connell,Peter G. Colman +17 more
TL;DR: Treatment with fenofibrate in individuals with type 2 diabetes mellitus reduces the need for laser treatment for diabetic retinopathy, although the mechanism of this effect does not seem to be related to plasma concentrations of lipids.
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy
Anthony C Keech,Paul Mitchell,Paula Summanen,Justin O'Day,Tme Davis,Michelle Moffitt,Mervi Taskinen,R. John Simes,David Tse,Elizabeth A. Williamson,Alistair Merrifield,Tiina Laatikainen,Michael C d'Emden,Dominique Crimet,Rachel O'Connell,Peter G. Colman +15 more
Journal ArticleDOI
Persistent Poststroke Hyperglycemia Is Independently Associated With Infarct Expansion and Worse Clinical Outcome
Tracey A. Baird,Mark W Parsons,Thanh G. Phan,Kenneth Butcher,Patricia Desmond,Brian M. Tress,Peter G. Colman,Brian R. Chambers,Stephen M. Davis +8 more
TL;DR: Persistent hyperglycemia on serial glucose monitoring is an independent determinant of infarct expansion and is associated with worse functional outcome and an urgent need to study normalization of blood glucose after stroke.
Journal ArticleDOI
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
Charles F. Verge,D Stenger,Ezio Bonifacio,Peter G. Colman,C Pilcher,P. J. Bingley,George S. Eisenbarth +6 more
TL;DR: IA-2/ICA512 autoantibodies are a marker of type 1 diabetes and can be measured consistently by most assays, and several different strategies for combining assays achieved high sensitivity with a low false-positive rate.